|
|
Volumn 20, Issue 23-24, 2002, Pages 2866-2872
|
|
Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell™ 2 vaccine
a
|
|
Author keywords
Feline leukemia virus; Non viraemic; Syndromes
|
|
Indexed keywords
FELINE LEUKEMIA VIRUS VACCINE;
NEUTRALIZING ANTIBODY;
FELINE LEUKEMIA VIRUS PROTEIN P27;
GAG PROTEIN;
ONCOPROTEIN;
VIRUS ANTIBODY;
VIRUS ANTIGEN;
VIRUS PROTEIN;
VIRUS VACCINE;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBODY BLOOD LEVEL;
ANTIBODY RESPONSE;
ANTIBODY TITER;
ARTICLE;
CAT;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
FELINE LEUKEMIA VIRUS;
IMMUNITY;
IMMUNIZATION;
IMMUNOASSAY;
INFECTION SENSITIVITY;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROTECTION;
VACCINATION;
VIREMIA;
VIRUS INFECTION;
ANIMAL;
ANIMAL DISEASE;
BLOOD;
CAT DISEASE;
FEMALE;
IMMUNOLOGY;
MOUTH;
NOSE;
PATHOGENICITY;
RETROVIRUS INFECTION;
SERODIAGNOSIS;
TIME;
VIRULENCE;
ANIMAL;
ANTIBODIES, VIRAL;
ANTIGENS, VIRAL;
CAT DISEASES;
CATS;
FEMALE;
GENE PRODUCTS, GAG;
LEUKEMIA VIRUS, FELINE;
MALE;
MOUTH;
NEUTRALIZATION TESTS;
NOSE;
RETROVIRIDAE INFECTIONS;
RETROVIRIDAE PROTEINS;
RETROVIRIDAE PROTEINS, ONCOGENIC;
TIME FACTORS;
TUMOR VIRUS INFECTIONS;
VIRAL VACCINES;
VIREMIA;
VIRULENCE;
ANIMALS;
|
|
EID: 0037178295
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(02)00237-2 Document Type: Article |
|
Times cited : (16)
|
|
References (19)
|
